Cash And Equivalent Changement Date
AbbVie USD 13.29B 4.53B 2023-09
Abbott USD 7.84B 1.33B 2023-06
Amgen USD 10.94B 23.8B 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Avrobio USD 105.84M 18.85M 2023-09
BioCryst Pharmaceuticals USD 397.59M 251.38M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
Enanta Pharmaceuticals USD 85.39M 9.79M 2023-09
GlaxoSmithKline GBP 3.18B 37M 2023-09
Incyte USD 3.21B 13.85M 2023-12
J&J USD 3.5B 497M 2023-09
Merck USD 8.6B 2.94B 2023-09
Nektar Therapeutics USD 64.92M 14.19M 2023-09
Pfizer USD 3.15B 516M 2023-09
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Takeda JPY 318.05B 1.67B 2023-09
TG Therapeutics USD 217.51M 66.61M 2023-12
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Xencor USD 53.79M 1.06M 2023-12



Karyopharm Therapeutics Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.